Idiopathic intracranial hypertension: diagnosis and management

2014 ◽  
Vol 4 (2) ◽  
pp. 29 ◽  
Author(s):  
PremS Subramanian
2019 ◽  
Vol 39 (06) ◽  
pp. 682-691
Author(s):  
Sarah R. Ahmad ◽  
Heather E. Moss

AbstractAdvances in ophthalmic diagnostics and results of interventional clinical trials are shifting diagnosis and management of idiopathic intracranial hypertension (IIH) to be more technology- and evidence-based. In this article, the evidence supporting current diagnostic criteria, evaluation, and medical and surgical management of IIH are reviewed.


2019 ◽  
Vol 34 (12) ◽  
pp. 751-756 ◽  
Author(s):  
Keerthi T. Gondi ◽  
Kevin S. Chen ◽  
Sean M. Gratton

Background: Idiopathic intracranial hypertension is a rare neurologic condition characterized by elevated intracranial pressure with normal cerebrospinal fluid analysis and neuroimaging. A subset of pediatric idiopathic intracranial hypertension patients are coincidentally found to have papilledema and elevated intracranial pressure without symptoms (eg, headache, visual blurring, tinnitus). This study aims to investigate the features of asymptomatic pediatric idiopathic intracranial hypertension. Methods: Retrospective case-control study of patients aged 0 to 18 years who received idiopathic intracranial hypertension diagnosis from 2005 to 2016. Subjects were included if they met established diagnostic criteria for idiopathic intracranial hypertension diagnosis. Subjects were classified as symptomatic if they presented with 1 symptom related to elevated intracranial pressure, and asymptomatic if no symptoms were present. Statistical analysis was performed to compare the 2 groups. Results: 12 (22.6%) of 53 pediatric idiopathic intracranial hypertension subjects were asymptomatic. Compared to symptomatic idiopathic intracranial hypertension, asymptomatic idiopathic intracranial hypertension had younger age of onset, lower initial opening pressure on lumbar puncture, lower optic nerve edema grades bilaterally, lower likelihood of globe flattening on magnetic resonance imaging (MRI), and smaller required dose of acetazolamide for resolution of papilledema (all P < .05). Conclusion: Asymptomatic idiopathic intracranial hypertension is common among pediatric patients with papilledema and is an important disease entity that requires special clinical management. It may exist as a milder version of idiopathic intracranial hypertension that occurs in younger children, or as a precursor state that later evolves into symptomatic disease.


2018 ◽  
Vol 256 (7) ◽  
pp. 1217-1224 ◽  
Author(s):  
Irini Chatziralli ◽  
Panagiotis Theodossiadis ◽  
George Theodossiadis ◽  
Ioannis Asproudis

2020 ◽  
Vol 20 (4) ◽  
pp. 384-388 ◽  
Author(s):  
Benjamin R Wakerley ◽  
Susan P Mollan ◽  
Alexandra J Sinclair

2017 ◽  
Vol 23 (2) ◽  
pp. 43-50
Author(s):  
Nihan Hande Akçakaya ◽  
Mehmet Osman Akçakaya ◽  
Altay Sencer ◽  
Zuhal Yapıcı

Sign in / Sign up

Export Citation Format

Share Document